Café

© 2026 Longbridge｜Terms of Service Privacy Policy

DWTX

DWTX

2.1403.88%( +0.080 )

LongbridgeAI

Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study | DWTX Stock News

StockTitan

May 17, 2026 at 11:45 PM

Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study | DWTX Stock News

Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study | DWTX Stock News

Login to unlock148characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Dogwood Therapeutics

USDWTX

+3.88%

iShares Global Healthcare

USIXJ

Invesco Biotechnology & Genome ETF

USPBE